Magnesium%2525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520sulphate

# Magnesium Sulphate ## Overview Magnesium sulphate is an essential mineral. It plays a crucial role in numerous biochemical reactions, including neuromuscular transmission and muscle contraction. It is available for parenteral and enteral administration. ## Primary Indications * Treatment and prevention of hypomagnesemia. * Management of severe pre-eclampsia and eclampsia. * Management of torsades de pointes. * Bronchodilator in acute exacerbations of asthma (adjunctive therapy). ## Adult Dosing * **Hypomagnesemia:** * **Acute symptomatic hypomagnesemia:** 1 to 4 grams (8 to 32 mEq) IV over 5 to 60 minutes. Further doses may be given every 4 hours as needed, or as a continuous infusion. * **Symptomatic hypomagnesemia:** 4 grams (32 mEq) IM divided into two doses (2 grams each buttock) every 4 hours as needed. Alternatively, 1 gram (8 mEq) per hour IV infusion for up to 12 hours. * **Asymptomatic hypomagnesemia:** Typically treated with oral magnesium salts, but if IV is required, consult specific protocols. * **Pre-eclampsia/Eclampsia:** Loading dose: 4 to 6 grams IV over 5 to 20 minutes. Maintenance dose: 1 to 2 grams per hour IV infusion. Repeat loading dose of 2 grams IV may be given if reflexes are lost or seizures occur. * **Torsades de Pointes:** 1 to 2 grams (8 to 16 mEq) IV in 10 mL of D5W over 5 to 10 minutes. May repeat bolus doses. Followed by a continuous infusion of 0.5 to 1 gram (4 to 8 mEq) per hour. * **Asthma (Adjunctive):** 2 grams (16 mEq) IV diluted in 50 mL of normal saline or D5W infused over 15 to 30 minutes. ## Pediatric Dosing Dosing for pediatric patients is highly variable and often guided by specific institutional protocols and the severity of the condition. * **Hypomagnesemia:** Typical doses range from 25 to 100 mg/kg/dose IV, not to exceed 2 grams per dose. Infuse over 10 to 30 minutes. May be repeated every 4 to 12 hours. * **Eclampsia:** Loading dose: 40 mg/kg IV over 5 to 20 minutes. Maintenance dose: 20 mg/kg/hour IV infusion. * **Asthma (Adjunctive):** 25 to 40 mg/kg IV over 15 to 30 minutes. Maximum dose typically 2 grams. ## Dose Adjustments * **Renal Impairment:** Magnesium is renally excreted. Use with caution in patients with impaired renal function. Dose reduction and close monitoring of serum magnesium levels and urine output are essential. In severe renal impairment, magnesium sulphate may be contraindicated. ## Contraindications * Hypermagnesemia. * Heart block greater than first degree. * Myocardial infarction. * Bowel obstruction. * Anuria. ## Adverse Effects Common adverse effects include flushing, sweating, hypotension, nausea, vomiting, and somnolence. More serious effects with toxicity include loss of deep tendon reflexes, respiratory depression, cardiac arrhythmias, coma, and cardiac arrest. ## Key Drug Interactions * **Neuromuscular Blocking Agents:** Magnesium can potentiate the effects of non-depolarizing and depolarizing neuromuscular blocking agents, potentially leading to prolonged neuromuscular blockade. * **Calcium Salts:** Concurrent administration may antagonize the effects of magnesium. * **Tetracyclines and Fluoroquinolones:** Magnesium may decrease the absorption of oral forms of these antibiotics. Separate administration by at least 2 hours. ## Monitoring * **Serum Magnesium Levels:** Essential, especially with repeated doses or prolonged infusions. Target levels vary by indication. * **Deep Tendon Reflexes:** Assess for presence and symmetry. Loss of reflexes indicates toxicity. * **Respiratory Rate and Depth:** Monitor for signs of respiratory depression. * **Blood Pressure and Heart Rate:** Assess for hypotension and cardiac arrhythmias. * **Urine Output:** Important for assessing renal function and magnesium excretion. * **Electrocardiogram (ECG):** May be useful in assessing for cardiac effects. ## Clinical Pearls * Magnesium sulphate for IV administration should be diluted. Consult specific product labeling and institutional guidelines for appropriate dilution and infusion rates. * Rapid IV infusion can cause hypotension and cardiac arrhythmias. * Magnesium toxicity is often reversible with cessation of magnesium administration and, if severe, calcium administration (e.g., calcium gluconate IV). * Oral magnesium supplements are often preferred for chronic or mild hypomagnesemia. *** **Disclaimer:** This information is intended for healthcare professionals. Always consult the most current prescribing information and institutional protocols before making any treatment decisions. Drug information can change rapidly.